Plastic Surgery Practice
  • Client Objectives
    • Aesthetics
    • Dermatology
    • Rejuvenation
  • Practice Management
    • Marketing
    • Office Management
    • Technology
  • Treatment Solutions
    • Innovations
    • Products
    • Pharmaceuticals
  • Resources
    • Podcasts
    • Videos
    • Webinars
    • White Papers

Select Page

Nestlé's Pharma Experiment Nears an End with $10B Skin Health Sale Talks

May 16, 2019 | Pharmaceuticals, Skin Conditions | 0 |

Just five years after Nestlé took full possession of dermatology specialist Galderma amid a pivot to pharma, the Swiss company is now in the final stage of bailing out of skin health as it refocuses on food and nutrition.
Nestlé has entered exclusive talks to sell its skin health unit to a consortium led by private equity EQT Partners for 10.2 billion Swiss francs ($10.1 billion), the company reports. The price tag is much higher than the previously rumored $7 billion.

Click here to view original web page at www.fiercepharma.com

Share:

Rate:

PreviousRealSelf Partners with The Aesthetic Society, Focuses on Patient Safety
NextSome Biologic Treatments for Psoriasis May Be Safer for Patients

Related Posts

Urbanism: The Modern Source of Skin Inflammation

Urbanism: The Modern Source of Skin Inflammation

February 10, 2017

Reconsider a Controversial Acne Drug, Study Urges

Reconsider a Controversial Acne Drug, Study Urges

March 16, 2020

Do Cosmetic, Medical Patients Get “Dual-Class” Treatment from Dermatologists?

Do Cosmetic, Medical Patients Get “Dual-Class” Treatment from Dermatologists?

July 31, 2008

NEA and PeDRA Announce 2020 Childhood Eczema Challenge Grant

NEA and PeDRA Announce 2020 Childhood Eczema Challenge Grant

March 9, 2020

Recent Posts

  • Letybo, a Botulinum Toxin Recently Approved in US, Expands to Malaysia
    Sep 15, 2025 | Injectibles
  • POP Recovery Systems and UPMC Plastic Surgery Center Partner to Raise Recovery Standards
    Sep 12, 2025 | Company News
  • New Book Explores Evolving Standards in Aesthetic Plastic Surgery
    Sep 11, 2025 | Patient Relations
  • FDA Greenlights New Hyaluronic Acid Dermal Filler, Introducing Brand to HA Filler Market
    Sep 10, 2025 | Injectibles
  • FDA Clears Dermalogica PRO Pen Microneedling Device
    Sep 10, 2025 | MicroNeedling

Plastic Surgery Practice

7300 W 110th St – Floor 7
Overland Park, KS 66210
(913) 955-2600

Our Parent Company

MEDQOR LLC

About MEDQOR

MEDQOR Data Platform

Press Releases

Key Resources

Podcasts

Webinars

White Papers

Videos

Helpful Links

Media Solutions Kit

Subscribe Now

Contact Us

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Copyright

Privacy Policy

Terms of Service

© 2024 MEDQOR LLC. All Rights Reserved